| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 02/07/2013 | WO2012073041A3 Inhibitors of apurinic/apyrimidinic endonuclease 1 (ape1) and their use |
| 02/07/2013 | WO2008127606A8 Process for making topotecan |
| 02/07/2013 | US20130035324 Heterocyclic compounds and uses thereof |
| 02/06/2013 | EP2552209A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 02/06/2013 | CN1938298B Methods for minimizing thioamide impurities |
| 02/06/2013 | CN102911179A Lcotinib hydrochloride crystal form, medicinal composition and application |
| 02/06/2013 | CN101874032B Novel naphthyridine derivative monohydrate and method for producing the same |
| 02/06/2013 | CN101389632B Spiroketals |
| 02/05/2013 | US8367673 Substituted diketopiperazines as oxytocin antagonists |
| 01/31/2013 | WO2013015984A1 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | WO2013014587A1 Heterocyclic amide derivatives as p2x7 receptor antagonists |
| 01/31/2013 | WO2013014162A1 Heterocyclyl pyrimidine analogues as jak inhibitors |
| 01/31/2013 | WO2013014060A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | WO2013013504A1 Tigecycline derivative |
| 01/31/2013 | US20130030182 Methods for the synthesis of tiotropium bromide |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130030011 Compounds for the reduction of beta-amyloid production |
| 01/31/2013 | US20130029995 Substituted Bicyclic Aromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands |
| 01/31/2013 | US20130029980 Flavin derivatives |
| 01/31/2013 | US20130029964 [5, 6] heterocyclic compound |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | CA2843245A1 N-(imidazolidin-2-ylidene)-heterocyclopenta[b]pyridine derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | CA2843195A1 Heterocyclyl pyrimidine analogues as jak inhibitors |
| 01/31/2013 | CA2843022A1 Substituted quinolines and their use as medicaments |
| 01/31/2013 | CA2838640A1 Heterocyclic amide derivatives as p2x7 receptor antagonists |
| 01/30/2013 | EP2550277A1 Substituted pyridazines having herbicidal action |
| 01/30/2013 | EP2550276A1 Substituted pyridines having herbicidal action |
| 01/30/2013 | EP2549868A1 Chemical compounds |
| 01/30/2013 | CN102906099A (+)-3-hydroxymorphinan-based polycycle derivatives as neuroprotectants |
| 01/30/2013 | CN102906096A Substituted pyridines having herbicidal action |
| 01/30/2013 | CN102898433A Tetrandrine gallate and drug composition, preparation method and applications thereof |
| 01/30/2013 | CN102898432A Tricyclic compound |
| 01/30/2013 | CN102898371A Chiral polycyclic piperidine derivative, synthetic method and application |
| 01/30/2013 | CN102898330A Colchicine derivative |
| 01/30/2013 | CN102086206B Fluorescence probes as well as preparation method and application thereof |
| 01/29/2013 | US8361500 Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2459822C Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents |
| 01/24/2013 | WO2013012723A1 Novel 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors |
| 01/24/2013 | WO2013012297A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013012296A1 Novel organic electroluminescence compounds and organic electroluminescence device using the same |
| 01/24/2013 | WO2013011891A1 Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same |
| 01/24/2013 | WO2013011461A1 Process for the preparation of asenapine maleate |
| 01/24/2013 | WO2013011285A1 Azetidine derivatives for treatment of melanin related disorders |
| 01/24/2013 | WO2013010382A1 Heterocyclic substituted pyrimidine compound |
| 01/24/2013 | WO2012099952A3 Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-ht6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia |
| 01/24/2013 | US20130023611 Weakly Basic Hindered Amines Compounds Having Carbonate Skeletons, Synthetic Resin Compositions And Coating Compositions |
| 01/24/2013 | US20130023568 Benzimidazole Derivatives And Their Pharmaceutical Compositions And Uses |
| 01/24/2013 | US20130023538 Heteroaryl Derivatives as CFTR Modulators |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023515 Novel spiropiperidine prolylcarboxypeptidase inhibitors |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023500 Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof |
| 01/24/2013 | US20130023415 Substituted Pyridines Having Herbicidal Action |
| 01/24/2013 | US20130020563 Polycyclic compounds and organic electroluminescence device employing the same |
| 01/24/2013 | CA2841645A1 Azetidine derivatives for treatment of melanin related disorders |
| 01/23/2013 | EP2547684A1 Spirocyclic compounds and their use as therapeutic agents and diagnostic probes |
| 01/23/2013 | EP2547338A2 Imidazopyridine compounds, compositions and methods of use |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102887905A Cis heterocyclic 1,2,3,4-tetrahydroisoquinoline derivatives and application thereof |
| 01/23/2013 | CN102887904A 2,3-dioxyethyl-5-methyl-8,9-dimethoxy benzophenanthridine derivative, and preparation method and application thereof |
| 01/23/2013 | CN101654456B Water-soluble derivants containing 10-hydroxycamptothecine and preparation method thereof |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/17/2013 | WO2013010102A2 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | WO2013010092A1 4-oxo-3,5,7,8-tetrahydro-4h-pyrano {4,3-d} pyrminidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | WO2013008217A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | WO2013007621A1 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/17/2013 | WO2013007361A1 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 01/17/2013 | WO2012068234A3 Antiviral compounds |
| 01/17/2013 | US20130018049 Azaindole Compounds and Methods for Treating HIV |
| 01/17/2013 | US20130018048 Oxazole derivatives useful as modulators of faah |
| 01/17/2013 | US20130018038 Chemical compounds |
| 01/17/2013 | US20130018030 New compounds, pharmaceutical compositions and uses thereof |
| 01/17/2013 | US20130018026 Halogenated phenols for diagnostics, antioxidant protection and drug delivery |
| 01/17/2013 | US20130017273 Compounds useful as inhibitors of atr kinase |
| 01/17/2013 | US20130017149 Pharmaceutical compounds |
| 01/17/2013 | CA2841932A1 4 - piperidinyl compounds for use as tankyrase inhibitors |
| 01/17/2013 | CA2841032A1 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 01/17/2013 | CA2837529A1 Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/16/2013 | CN102884067A Prophylactic or therapeutic medication for inner ear disorders |
| 01/16/2013 | CN102875627A Stemona sessilifolia alkaloid salt and its pharmaceutical application |
| 01/16/2013 | CN102875561A Extracting method of hernandezine |
| 01/16/2013 | CN102875560A 5-substituted tetrandrine compound and application thereof in preparing anticarcinogen sensitizer |
| 01/16/2013 | CN102875559A Method for extracting simulenoline from zanthoxylum simulans hance |
| 01/16/2013 | CN102875558A 2-chloro-4-substituted-8-nitrobenzofuran [3,2-d] miazines compound, preparation method of compound and application of compound |
| 01/16/2013 | CN102872915A Iron catalyst system for preparation of pyridine derivatives and its application |
| 01/15/2013 | US8354394 Diuretics |
| 01/10/2013 | WO2013006738A1 Compounds for the treatment of hiv |
| 01/10/2013 | WO2013005354A1 Heterocyclic compound |
| 01/10/2013 | WO2013005041A1 Tricyclic heterocyclic compounds as kinase inhibitors |
| 01/10/2013 | WO2013004984A1 Tricyclic compounds for use as kinase inhibitors |
| 01/10/2013 | WO2012096832A3 Hdac inhibiting derivatives of camptothecin |
| 01/10/2013 | US20130012563 Crystalline (1r,4r)-6'-fluoro-n,n-dimethyl-4-phenyl-4',9'-dihydro-3'h-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine |
| 01/10/2013 | US20130012530 New Positive allosteric modulators of nicotinic acetylcholine receptor |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012434 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 01/10/2013 | US20130012389 Substituted Pyridazines Having Herbicidal Action |
| 01/10/2013 | CA2840095A1 Compounds for the treatment of hiv |
| 01/09/2013 | EP2543670A1 Pyrazolopyrimidine derivative |